
|
DrugPatentWatch concentrates deep knowledge on more than 6,400 small-molecule drugs and 2,300 generic ingredients from 1,700 branded and generic pharmaceutical companies and 700 suppliers, and more than 4,400 active and expired US patents and 74,000 international patents spanning 93 countries and regional patent offices. |
| Title: | Formulation for lipophilic agents |
| Abstract: | The invention relates to pharmaceutical formulations of lipophilic therapeutic agents in which such agents are solubilized in largely aqueous vehicles, and processes for preparing and using the same. |
| Inventor(s): | Mazess; Richard B. (Madison, WI), Driscoll; Jeffrey W. (Middleton, WI), Goldensoph; Creighton Reed (DeForest, WI), LeVan; Leon W. (Oregon, WI) |
| Assignee: | Genzyme Corporation (Cambridge, MA) |
| Application Number: | 10/247,765 |
| Patent Claim Types: see list of patent claims | Formulation; Compound; Use; |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Type | RLD | Patent No. | Product | Substance | Delist_Flag | Patent Expiration | Patented / Exclusive Use | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Genzyme Corp | HECTOROL | doxercalciferol | INJECTABLE; INJECTION | 021027 | Apr 6, 2000 | RX | No | 7,148,211 | Y | Y | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Genzyme Corp | HECTOROL | doxercalciferol | INJECTABLE; INJECTION | 021027 | Apr 6, 2000 | RX | Yes | 7,148,211 | Y | Y | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| The preview shows a limited data set. Complete access is available with a Subscription | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
| Inter partes reexamination | |||||||||
| Filing: | 7,148,211, Reexam. C.N.: 95/001,245, Requested Date: Oct. 13, 2009, Cl.: 514/168, Title: FORMULATION FOR LIPOPHILIC AGENTS, Inventor: Richard B. Mazess et al., Owners of Record: Genzyme Corporation, Cambridge, MA, Attorney or Agent: Michael Best & Friedrich, LLP., Madison, WI, Ex. Gp.: 3991, Requester: Third Party Requester: Cobrek Pharmaceuticals, Inc., (Att'y Is: Robert S. Silver, Caesar Rivise Bernstein Cohen And Pokotilow LTD., Philadelphia, PA), Real Party in Interest: Same As Third Party Requester | ||||||||
| Inter partes reexamination | |||||||||
| Filing: | 7,148,211, Reexam. C.N.: 95/001,245, Requested Date: Oct. 13, 2009, Cl.: 514/168, Title: FORMULATION FOR LIPOPHILIC AGENTS, Inventor: Richard B. Mazess et al., Owners of Record: Genzyme Corporation, Cambridge, MA, Attorney or Agent: Michael Best & Friedrich, LLP., Madison, WI, Ex. Gp.: 3991, Requester: Third Party Requester: Cobrek Pharmaceuticals, Inc., (Att'y Is: Robert S. Silver, Caesar Rivise Bernstein Cohen And Pokotilow LTD., Philadelphia, PA), Real Party in Interest: Same As Third Party Requester | ||||||||
| Country | Document Number | Publication Date | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Australia | 2003267131 | Apr 08, 2004 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Brazil | 0314354 | Jul 19, 2005 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Canada | 2498331 | Apr 01, 2004 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| China | 100349573 | Nov 21, 2007 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| The preview shows a limited data set. Complete access is available with a Subscription | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639